Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 17 04:00PM ET
127.64
Dollar change
-2.14
Percentage change
-1.65
%
IndexS&P 500 P/E17.23 EPS (ttm)7.41 Insider Own1.67% Shs Outstand88.82M Perf Week-3.35%
Market Cap11.19B Forward P/E12.21 EPS next Y10.46 Insider Trans-8.84% Shs Float86.23M Perf Month-6.85%
Income691.53M PEG1.15 EPS next Q1.95 Inst Own91.98% Short Float4.80% Perf Quarter21.97%
Sales12.14B P/S0.92 EPS this Y9.81% Inst Trans-2.64% Short Ratio4.91 Perf Half Y71.17%
Book/sh11.89 P/B10.74 EPS next Y12.42% ROA3.92% Short Interest4.14M Perf Year52.21%
Cash/sh5.43 P/C23.51 EPS next 5Y15.00% ROE78.21% 52W Range71.51 - 141.54 Perf YTD21.84%
Dividend Est.- P/FCF7.48 EPS past 5Y51.82% ROI5.93% 52W High-9.82% Beta1.06
Dividend TTM- Quick Ratio1.13 Sales past 5Y1.27% Gross Margin25.33% 52W Low78.49% ATR (14)2.85
Dividend Ex-Date- Current Ratio1.19 EPS Y/Y TTM30.63% Oper. Margin13.19% RSI (14)36.73 Volatility2.09% 1.83%
Employees70000 Debt/Eq10.53 Sales Y/Y TTM4.57% Profit Margin5.70% Recom3.00 Target Price131.66
Option/ShortYes / Yes LT Debt/Eq10.04 EPS Q/Q173.11% Payout0.00% Rel Volume0.66 Prev Close129.78
Sales Surprise4.57% EPS Surprise14.73% Sales Q/Q7.85% EarningsFeb 13 AMC Avg Volume842.23K Price127.64
SMA20-5.05% SMA50-1.01% SMA20020.07% Trades Volume554,965 Change-1.65%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Apr-17-24 07:31PM
Apr-12-24 05:50PM
Apr-10-24 01:35PM
09:40AM
09:00AM
09:00AM Loading…
09:00AM
Apr-08-24 06:00PM
Apr-02-24 09:40AM
Mar-25-24 10:59AM
10:46AM
09:40AM
Mar-24-24 05:49AM
Mar-22-24 09:52AM
Mar-21-24 12:00PM
Mar-19-24 05:10AM
09:40AM Loading…
Mar-15-24 09:40AM
Mar-14-24 11:30AM
Mar-11-24 04:40PM
Mar-08-24 05:20PM
09:40AM
05:44AM
Mar-06-24 10:09AM
09:49AM
09:15AM
Mar-05-24 04:50PM
04:19PM
03:34PM
10:08AM
09:00AM
Feb-29-24 07:19PM
11:23PM Loading…
Feb-28-24 11:23PM
Feb-27-24 07:47AM
Feb-23-24 12:00PM
Feb-22-24 10:31AM
09:50AM
Feb-21-24 12:20PM
09:40AM
Feb-20-24 01:53AM
Feb-15-24 09:15AM
08:50AM
12:22AM
Feb-14-24 07:08PM
11:44AM
09:10AM
Feb-13-24 08:14PM
08:00PM
05:20PM
04:50PM
04:36PM
04:08PM
Feb-12-24 06:02AM
Feb-09-24 10:51AM
06:15AM
Feb-01-24 09:40AM
Jan-31-24 03:55PM
Jan-23-24 02:00PM
Jan-22-24 09:50AM
Jan-19-24 09:40AM
Jan-16-24 09:40AM
Dec-30-23 09:26AM
04:30AM
Dec-29-23 12:34PM
Dec-26-23 09:59AM
Dec-25-23 09:40AM
Dec-19-23 10:00AM
Dec-08-23 09:40AM
Dec-07-23 11:31AM
Nov-30-23 10:00AM
Nov-28-23 06:30AM
04:03AM
Nov-27-23 11:20AM
09:07AM
Nov-22-23 10:40AM
09:40AM
Nov-15-23 11:54PM
Nov-13-23 09:31AM
Nov-10-23 12:00PM
Nov-09-23 09:55AM
Nov-08-23 05:46PM
12:22PM
10:56AM
07:27AM
01:33AM
Nov-07-23 10:07PM
08:30PM
04:44PM
04:40PM
04:05PM
09:40AM
Nov-06-23 09:40AM
Nov-03-23 12:21PM
Nov-02-23 12:05PM
Oct-25-23 12:33PM
Oct-24-23 07:00AM
Oct-23-23 10:15AM
09:40AM
08:00AM
Oct-20-23 09:40AM
Oct-18-23 04:52PM
12:00PM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 13 '24Option Exercise52.4150,0002,620,500102,748Mar 15 06:13 PM
Rodriguez JavierChief Executive OfficerMar 06 '24Option Exercise67.80750,00050,850,0001,244,480Mar 08 05:04 PM
ACKERMAN JOELCFO and TreasuerMar 06 '24Option Exercise52.4155,0002,882,550195,360Mar 08 05:04 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 06 '24Option Exercise52.4150,0002,620,50087,687Mar 08 05:05 PM
Rodriguez JavierChief Executive OfficerFeb 28 '24Option Exercise67.8050,0003,390,000531,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 27 '24Sale126.877,397938,467481,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Option Exercise67.80450,00030,510,000889,002Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Sale126.1167,6038,525,130488,697Feb 28 05:51 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Option Exercise52.41100,0005,241,000137,687Feb 23 05:44 PM
ACKERMAN JOELCFO and TreasuerFeb 21 '24Option Exercise52.4155,0002,882,550178,726Feb 23 05:43 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Option Exercise52.4140,0002,096,400121,297Feb 23 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Sale119.8129,4883,533,02537,687Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Sale120.7311,2851,362,43881,297Feb 23 05:44 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Option Exercise54.4054,6082,970,47878,448Feb 20 08:37 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Sale119.6426,1643,130,26920,264Feb 20 08:37 PM
Rodriguez JavierChief Executive OfficerDec 14 '23Option Exercise67.80500,00033,900,000833,299Dec 18 06:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22 '23Option Exercise52.4140,0002,096,400121,297Aug 24 06:54 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 22 '23Sale101.819,794997,09981,297Aug 24 06:54 PM
YALE PHYLLIS RDirectorMay 12 '23Option Exercise66.297,165474,96820,275May 12 09:31 PM
YALE PHYLLIS RDirectorMay 12 '23Sale95.262,196209,19513,110May 12 09:31 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMay 10 '23Option Exercise66.29243,99416,174,362348,071May 12 09:34 PM
Rodriguez JavierChief Executive OfficerMay 10 '23Option Exercise66.2988,2135,847,640403,835May 12 09:20 PM
ACKERMAN JOELCFO and TreasuerMay 10 '23Option Exercise66.2956,3063,732,525191,097May 12 08:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10 '23Option Exercise66.2933,7842,239,541135,164May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10 '23Option Exercise66.2926,2761,741,83658,835May 12 08:48 PM
DESOER BARBARA JDirectorMay 10 '23Option Exercise66.297,165474,9687,165May 12 08:46 PM
NEHRA JOHN MDirectorMay 10 '23Option Exercise66.297,165474,9687,165May 12 08:50 PM
Rodriguez JavierChief Executive OfficerMay 10 '23Sale99.4416,9161,682,089315,622May 12 09:20 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffMay 10 '23Sale99.2415,9411,581,99091,245May 12 09:15 PM
HEARTY JAMES OChief Compliance OfficerMay 10 '23Sale101.645,745583,91432,559May 12 08:48 PM
DESOER BARBARA JDirectorMay 10 '23Sale101.612,449248,8430May 12 08:46 PM
Last Close
Apr 17 04:00PM ET
346.08
Dollar change
-0.77
Percentage change
-0.22
%
CI Cigna Group daily Stock Chart
IndexS&P 500 P/E19.90 EPS (ttm)17.39 Insider Own1.82% Shs Outstand292.50M Perf Week-3.29%
Market Cap98.17B Forward P/E10.82 EPS next Y32.00 Insider Trans-3.07% Shs Float278.49M Perf Month-1.86%
Income5.16B PEG1.67 EPS next Q6.22 Inst Own91.60% Short Float2.00% Perf Quarter12.19%
Sales195.19B P/S0.50 EPS this Y13.29% Inst Trans-1.54% Short Ratio3.52 Perf Half Y10.88%
Book/sh158.03 P/B2.19 EPS next Y12.57% ROA3.59% Short Interest5.57M Perf Year33.79%
Cash/sh- P/C- EPS next 5Y11.95% ROE11.34% 52W Range240.50 - 365.71 Perf YTD15.57%
Dividend Est.6.76 (1.95%) P/FCF9.59 EPS past 5Y10.54% ROI6.90% 52W High-5.37% Beta0.59
Dividend TTM5.09 (1.47%) Quick Ratio- Sales past 5Y48.25% Gross Margin- 52W Low43.90% ATR (14)5.31
Dividend Ex-DateMar 05, 2024 Current Ratio0.77 EPS Y/Y TTM-18.94% Oper. Margin4.59% RSI (14)39.81 Volatility1.84% 1.33%
Employees72500 Debt/Eq0.68 Sales Y/Y TTM8.42% Profit Margin2.65% Recom1.54 Target Price385.86
Option/ShortYes / Yes LT Debt/Eq0.62 EPS Q/Q-8.73% Payout28.29% Rel Volume0.90 Prev Close346.85
Sales Surprise4.58% EPS Surprise3.86% Sales Q/Q11.65% EarningsMay 02 BMO Avg Volume1.58M Price346.08
SMA20-2.98% SMA50-0.07% SMA20013.43% Trades Volume1,426,524 Change-0.22%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Overweight $393
Feb-05-24Upgrade RBC Capital Mkts Sector Perform → Outperform $327 → $354
Feb-05-24Upgrade Cantor Fitzgerald Neutral → Overweight $334 → $372
Feb-01-24Upgrade Deutsche Bank Hold → Buy $355 → $370
Jan-04-24Upgrade Bernstein Mkt Perform → Outperform $330 → $372
Dec-11-23Upgrade Jefferies Hold → Buy $335 → $341
Aug-18-23Downgrade Edward Jones Buy → Hold
Jun-06-23Upgrade BofA Securities Neutral → Buy $320
Apr-21-23Initiated Cantor Fitzgerald Neutral $285
Apr-05-23Upgrade Raymond James Outperform → Strong Buy $350
Apr-17-24 12:10PM
Apr-16-24 01:47PM
10:01AM
04:13AM
Apr-15-24 04:46AM
06:15PM Loading…
Apr-12-24 06:15PM
09:40AM
Apr-11-24 09:00AM
Apr-09-24 01:16PM
Apr-04-24 06:15PM
Apr-03-24 04:09PM
02:46PM
Apr-02-24 04:01PM
11:33AM
07:04AM
03:43PM Loading…
Apr-01-24 03:43PM
Mar-31-24 11:03PM
Mar-30-24 01:00PM
Mar-28-24 04:05PM
09:33AM
Mar-27-24 06:15PM
09:40AM
Mar-25-24 09:30AM
Mar-24-24 11:00AM
Mar-21-24 08:02PM
Mar-18-24 06:15PM
Mar-14-24 09:15AM
Mar-12-24 06:15PM
10:24AM
Mar-08-24 11:16AM
10:32AM Loading…
10:32AM
10:15AM
09:13AM
05:31AM
01:57AM
Mar-07-24 06:22PM
03:03PM
01:47PM
01:12PM
09:30AM
07:13AM
07:10AM
06:54AM
06:45AM
Mar-06-24 11:56AM
Mar-05-24 10:54AM
Mar-04-24 05:02AM
Mar-01-24 12:07AM
Feb-29-24 09:50AM
Feb-28-24 09:10AM
Feb-27-24 09:40AM
09:15AM
09:00AM
Feb-26-24 04:18PM
Feb-24-24 03:37PM
Feb-21-24 10:07AM
09:12AM
01:34AM
Feb-20-24 04:30PM
12:00PM
07:30AM
Feb-17-24 01:29PM
Feb-15-24 06:00AM
04:51AM
Feb-14-24 01:41PM
Feb-13-24 07:00AM
Feb-11-24 08:00AM
Feb-09-24 09:42AM
Feb-08-24 06:09PM
11:50AM
09:15AM
Feb-06-24 02:00PM
09:40AM
Feb-05-24 01:00PM
10:10AM
08:18AM
Feb-03-24 08:51AM
12:11AM
Feb-02-24 07:40PM
03:15PM
03:04PM
01:20PM
12:56PM
12:42PM
10:58AM
10:57AM
10:46AM
10:17AM
10:15AM
09:30AM
09:16AM
07:33AM
07:10AM
06:33AM
06:18AM
06:03AM
06:00AM
02:55AM
Feb-01-24 05:23PM
09:58AM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cordani DavidChairman & CEOMar 26 '24Option Exercise139.227,7611,080,486355,815Mar 28 05:14 PM
Cordani DavidChairman & CEOMar 25 '24Option Exercise139.2231,2094,344,917379,263Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 25 '24Sale355.1731,20911,084,357348,054Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 22 '24Option Exercise139.226,338882,376354,392Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 22 '24Sale355.116,3382,250,682348,054Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 21 '24Option Exercise139.222,293319,231350,347Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 21 '24Sale355.022,293814,052348,054Mar 25 06:19 PM
Cordani DavidChairman & CEOMar 14 '24Option Exercise139.227,6161,060,300348,054Mar 14 06:09 PM
Cordani DavidChairman & CEOMar 13 '24Option Exercise139.2213,7611,915,806354,199Mar 14 06:09 PM
Cordani DavidChairman & CEOMar 13 '24Sale347.3313,7614,779,542340,438Mar 14 06:09 PM
Cordani DavidChairman & CEOMar 12 '24Option Exercise139.222,238311,574342,676Mar 14 06:09 PM
Cordani DavidChairman & CEOMar 12 '24Sale345.002,238772,121340,438Mar 14 06:09 PM
Cordani DavidChairman & CEOMar 08 '24Option Exercise139.222,801389,955343,239Mar 11 05:38 PM
Cordani DavidChairman & CEOMar 08 '24Sale345.192,801966,883340,438Mar 11 05:38 PM
Cordani DavidChairman & CEOMar 07 '24Option Exercise139.222,412335,799342,850Mar 11 05:38 PM
Cordani DavidChairman & CEOMar 07 '24Sale345.732,412833,892340,438Mar 11 05:38 PM
Cordani DavidChairman & CEOMar 04 '24Sale332.6219,2886,415,575340,438Mar 05 05:43 PM
Jones Nicole SSee RemarksMar 04 '24Sale332.624,4361,475,50231,587Mar 05 05:43 PM
Triplett Michael WSpecial AdvisorMar 04 '24Sale332.621,953649,60732,452Mar 05 05:43 PM
Cordani DavidChairman & CEOFeb 27 '24Option Exercise139.222,000278,440338,783Feb 27 05:48 PM
Cordani DavidChairman & CEOFeb 27 '24Sale345.042,000690,075336,783Feb 27 05:48 PM
Cordani DavidChairman & CEOFeb 26 '24Option Exercise139.2210,4531,455,267347,236Feb 27 05:48 PM
Cordani DavidChairman & CEOFeb 26 '24Sale345.7010,4533,613,652336,783Feb 27 05:48 PM
Cordani DavidChairman & CEOFeb 23 '24Option Exercise139.226,319879,731343,102Feb 27 05:48 PM
Cordani DavidChairman & CEOFeb 23 '24Sale345.246,3192,181,592336,783Feb 27 05:48 PM
Palmer Eric PSee RemarksFeb 14 '24Option Exercise149.13905134,96745,554Feb 15 05:30 PM
Cordani DavidChairman & CEOFeb 13 '24Option Exercise139.227,4621,038,860336,783Feb 13 05:27 PM
Palmer Eric PSee RemarksFeb 13 '24Option Exercise149.135,168770,73050,732Feb 15 05:30 PM
Palmer Eric PSee RemarksFeb 13 '24Sale340.006,0832,068,22044,649Feb 15 05:30 PM
Cordani DavidChairman & CEOFeb 12 '24Option Exercise139.222,073288,603331,394Feb 13 05:27 PM
Cordani DavidChairman & CEOFeb 12 '24Sale336.812,073698,198329,321Feb 13 05:27 PM
Cordani DavidChairman & CEOFeb 09 '24Option Exercise139.2238,0655,299,409367,386Feb 13 05:27 PM
Cordani DavidChairman & CEOFeb 09 '24Sale335.2238,06512,760,123329,321Feb 13 05:27 PM
Palmer Eric PSee RemarksFeb 09 '24Sale335.261,017340,95645,564Feb 13 05:28 PM
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. OfficerFeb 07 '24Option Exercise78.034,867379,7966,969Feb 09 05:04 PM
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. OfficerFeb 07 '24Sale330.484,8671,608,4462,102Feb 09 05:04 PM
Palmer Eric PSee RemarksFeb 05 '24Option Exercise139.221,017141,58746,581Feb 06 09:02 PM
Palmer Eric PSee RemarksFeb 02 '24Option Exercise139.225,684791,32651,248Feb 06 09:02 PM
Palmer Eric PSee RemarksFeb 02 '24Sale325.005,6841,847,30045,564Feb 06 09:02 PM
Ryan CynthiaEVP, CHROAug 30 '23Option Exercise149.1343464,7255,937Aug 31 05:33 PM
Ryan CynthiaEVP, CHROAug 29 '23Option Exercise149.133,012449,1959,271Aug 31 05:33 PM
Ryan CynthiaEVP, CHROAug 29 '23Sale282.223,7681,063,4055,503Aug 31 05:33 PM
Jones Nicole SEVP, General CounselAug 21 '23Sale276.867,8192,164,76830,069Aug 23 05:19 PM
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. OfficerAug 08 '23Option Exercise78.034,500351,15814,343Aug 10 05:07 PM
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. OfficerAug 08 '23Sale291.0012,2503,564,7502,093Aug 10 05:07 PM
Evanko Brian CEVP, Chief Financial OfficerAug 03 '23Option Exercise78.0357044,48031,902Aug 04 05:21 PM
Evanko Brian CEVP, Chief Financial OfficerAug 02 '23Option Exercise78.032,307180,02733,639Aug 04 05:21 PM
Evanko Brian CEVP, Chief Financial OfficerAug 02 '23Sale300.002,307692,10031,332Aug 04 05:21 PM
Neville EverettEVP, Solutions & Corp Devt.Jul 20 '23Option Exercise211.141,050221,7015,987Jul 21 05:03 PM
Neville EverettEVP, Solutions & Corp Devt.Jul 19 '23Option Exercise213.0513,1572,803,07718,094Jul 21 05:03 PM
Neville EverettEVP, Solutions & Corp Devt.Jul 19 '23Sale295.2113,1573,884,0784,937Jul 21 05:03 PM
Sanford Paul AEVP OperationsJul 19 '23Sale295.211,507444,8818,679Jul 21 05:03 PM
Neville EverettEVP, Solutions & Corp Devt.Jul 10 '23Sale277.61466129,3664,937Jul 12 06:43 PM
ZARCONE DONNA FDirectorMay 01 '23Sale253.29757191,74125,558May 03 05:22 PM